Cleveland, OH – September 15, 2026 – Checkpoint Surgical, Inc., a leader in intraoperative nerve care and regeneration, will participate in the 81st Annual Meeting of the American Society for Surgery of the Hand (ASSH) being held in Boston, MA, from September 17-19, 2026. The ASSH Annual Meeting will bring over 2,500 professional attendees to the John B. Hynes Convention Center to discuss the latest advancements and innovations in the hand and upper-extremity field.
Attendees will have the opportunity to speak with Checkpoint Surgical representatives at Booth 1831 in the Solutions Center and explore the company’s expanding portfolio of peripheral nerve care solutions. The meeting will also offer attendees an opportunity to see the newly launched CHECKPOINT AxioCor™ Flexible Nerve Conduit, Checkpoint’s latest addition to its nerve repair and regeneration portfolio.
Additionally, Checkpoint Surgical will host an Industry Forum on Thursday, September 17, 2026 at 11:30am. The session is titled, “Advancing Upper Limb Spasticity Care: A Case-Based Expert Panel on Nerve-Based Surgical Innovation” and faculty includes Wee Leon Lam, MBBS, Caroline Leclercq, MD, Peter C. Rhee, DO, Sami H. Tuffaha, MD.
“ASSH is an important opportunity for us to connect with surgeons who are advancing the field of hand and upper extremity care,” said Derek Lewis, President and Chief Executive Officer of Checkpoint Surgical. “We’re excited to showcase the continued expansion of our peripheral nerve portfolio, including the newly launched CHECKPOINT AxioCor™, while creating opportunities for meaningful education and discussion around emerging approaches to nerve care.”
About ASSH
ASSH is a medical specialty society founded in 1946 dedicated to the science and practice of hand and upper extremity surgery. The organization is home to more than 5,000 members who are medical professionals in the field of hand surgery. Learn more about ASSH at www.assh.org.
About Checkpoint Surgical
Checkpoint Surgical supports more peripheral nerve procedures than any other device company, providing surgeons with a comprehensive continuum of care for nerve surgery. The company’s product portfolio includes the CHECKPOINT GUARDIAN® Nerve Stimulator, CHECKPOINT GEMINI® Bipolar Nerve Stimulator, CHECKPOINT ACMShield® Soft Tissue Barrier, CHECKPOINT EDGE® Nerve Cutting Kit, the CHECKPOINT Regen10® Nerve Regeneration System (currently approved for use in Canada) and now, the CHECKPOINT AxioCor™ Flexible Nerve Conduit. These products address the complete spectrum of peripheral nerve care, from nerve identification and preservation to repair and regeneration.
Based in Cleveland, Ohio, Checkpoint Surgical is a privately held medical device company dedicated to advancing the science and practice of peripheral nerve care through research, education, and innovative product development. In collaboration with surgeons, the company develops technologies that help protect, assess, and regenerate peripheral nerves. Checkpoint Surgical’s industry leading intraoperative nerve stimulation devices have become the standard of care, and its expanding portfolio of surgical solutions is designed to support the entire continuum of intraoperative nerve care. For more information about Checkpoint Surgical, visit www.checkpointsurgical.com.
0136-MKT-0193-A
